U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07625150) titled 'FDG PET/MRI Imaging of Patellofemoral Joint Osteoarthritis' on May 22.
Brief Summary: This project aims to develop an [18F] fluorodeoxyglucose (FDG) positron emission tomography (PET) / magnetic resonance imaging (MRI) method to locate the painful inflammation in PFJ OA associated with joint loading. [18F] FDG PET/MRI is an emerging pain imaging approach with enhanced sensitivity to painful hypermetabolic inflammation through evaluation of intracellular glucose utilization rate via ([18F]FDG PET) and fine anatomy details (MRI). The investigative group has shown its promise in revealing previously unidentified or unspecified pain gene...